Trademark: 79142730
Word
EXELTIS RETHINKING HEALTHCARE
Status
Registered
Status Code
707
Status Date
Sunday, June 12, 2022
Serial Number
79142730
Registration Number
4792387
Registration Date
Tuesday, August 18, 2015
Mark Type
3
Filing Date
Wednesday, September 11, 2013
Published for Opposition
Tuesday, June 2, 2015

Trademark Owner History
CHEMO IBERICA, S.A. - Original Registrant

Classifications
5 Pharmaceutical preparations for [ use in ] the treatment of ophthalmic diseases and disorders, dermatological diseases and disorders, digestive diseases and disorders, gynecological diseases and disorders; reagents for use in pregnancy tests; medical diagnostic reagents for use in ovulation tests; medical diagnostic reagents for use in testing for diabetes; contraceptives; pharmaceutical preparations for use in the treatment of hormonal diseases and disorders, blood disorders, cancer, cardiovascular diseases, [ vascular diseases, ] [ gastro-intestinal diseases, genitourinary diseases, ] * gastrointestinal disease, genitourinary disorders, * immunological diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders; pharmaceutical preparations for [ use in the ] treatment of [ neurological diseases and disorders, psychiatric diseases, diseases of the central nervous system, ] diseases of the musculoskeletal system, diseases of the respiratory system, [ diseases of the circulatory system, ] * circulatory diseases, * viral diseases, glaucoma, dental and mouth diseases, [ headaches, migraines, ] obesity, cholesterol, [ in liver treatment ] * treatment of the liver * ; nutraceutical preparations for use as a dietary supplement; pharmaceutical [ preparations ] * products * for treating blood pressure and rheumatism; veterinary preparations for the treatment of digestive diseases and disorders, gynecological diseases and disorders, blood disorders, cancer, [ the ] treatment of cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunological [ diseases, ] * disorders, * infectious diseases, inflammatory diseases, metabolic diseases and disorders, [ the ] [ treatment of neurological diseases, ] the treatment of viral diseases, glaucoma, dental and oral diseases, [ headaches, migraines, ] obesity, [ liver treatment ] * treatment of the *, cholesterol; nutraceutical veterinary preparations for use as a dietary supplement; veterinary preparations for the treatment of blood pressure and for rheumatism; and dietetic foods, namely, crackers adapted for medical use * ; none of the aforesaid products are preparations in connection with neuroscience, including dementia, Alzheimer's disease and Parkinson's disease *
35 Sales promotion for third parties, business management assistance; [ consulting ] * consultancy * on business management and marketing studies; presentation of goods on [ any kind of ] * all * communication media for retail sale; commercial administration of licenses for the goods and services of others; organization of exhibitions, [ trade fairs or congresses for business ] * trade fairs and conventions for commercial * or advertising purposes, all relating to pharmaceutical, veterinary and biotechnological companies and for pharmaceutical, veterinary and biotechnological products * ; but none of the aforesaid goods relating to neuroscience, including dementia, Alzheimer's disease and Parkinson's disease or to goods in the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease *
10 [ Surgical apparatus and instruments, medical instruments for treating gynecological disorders, [ ophthalmological ] * ophthalmic * disorders, dermatological disorders, and respiratory and metabolic disorders; Medical test kits for diabetes monitoring for home use; orthopedic devices for diagnostic and therapeutic [ use ] * purposes * ; suture materials ]
42 [ Chemical, biological and pharmaceutical research services * ; [ all ] * none of * the aforesaid goods relating to the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease * ]
In the Statement, Page 1, lines 12 and 13, "gastro-intestinal diseases, genitourinary diseases" should be deleted, and, "gastrointestinal diseases, genitourinary disorders" should be inserted, and, In the Statement, Page 1, line 15, "use in the" should be deleted, and, In the Statement,Page 1, lines 16-18, "neurological diseases and disorders, psychiatric diseases, diseases of the central nervous system," should be deleted, and, In the Statement, Page 1, line 19, "diseases of the circulatory system," should be deleted, and, "circulatory diseases," should be inserted, and, In the Statement, Page 1, line 20, "headaches, migraines," should be deleted, and, In the Statement, Page 1, line 21, "in liver treatment" should be deleted, and, "treatment of the liver" should be inserted, and, "preparations" should be deleted, and, "products" should be inserted and In the Statement, Page 1, lines 25 and 28, "the" should be deleted, and, In the Statement, Page 1, line 27, " immunological diseases" should be deleted, and, "immunological disorders" should be inserted, and, In the Statement, Page 1, line 30, " headaches, migraines" should be deleted, and, In the Statement, Page 1, line 31, "liver treatment" should be deleted, and, "treatment of the liver" should be inserted, and, In the Statement, Page 1, line 34, after USE, "; none of the aforesaid products are preparations in connection with neuroscience, including dementia, Alzheimer's disease and Parkinson's disease" should be inserted, and, In the Statement, Page 2, line 2,"ophthalmological" should be deleted, and, "ophthalmic" should be inserted, and, In the Statement, Page 2, line 5, "use" should be deleted, and, "purposes" should be inserted, and, In the Statement, Page 2, line, 8, "consulting" should be deleted, and, "consultancy" should be inserted, and, In the Statement, Page 2, line 9, "any kind of" should be deleted, and, "all" should be inserted, and, In the Statement, Page 2, lines 11 and 12, "trade fairs or congresses for business" should be deleted, and, "trade fairs and conventions for commercial" should be inserted, and, In the Statement, Page 2, line 14, after PRODUCTS, "; but none of the aforesaid goods relating to neuroscience, including dementia, Alzheimer's disease and Parkinson's disease or to goods in the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease" should be inserted, and, In the Statement, Page 2, line 16, after SERVICES, "; all the aforesaid goods relating to the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease" should be inserted.
The mark consists of the word "Exeltis" in dark blue, in rounded font and with the first letter capitalized, under which there is the phrase "Rethinking healthcare" in light blue, also in rounded font but smaller in size lower and with only the first letter of the first word capitalized. To the left of these words is a logo in dark blue and light blue consisting of seven leaves of diminishing size linked at their bases and opening in array with tips pointing outwards.
In the statement, Page 2, line 7, "all" should be deleted, and "none of" should be inserted.
In the statement, Page 1, line 5 "USE IN" should be deleted. In the statement, Page 1, line 12, "VASCULAR DISEASES," should be deleted. In the statement, Page 1, lines 27-28, "TREATMENT OF NEUROLOGICAL;" should be deleted.
The color(s) dark blue and light blue is/are claimed as a feature of the mark.
"HEALTHCARE"

Trademark Events
Feb 24, 2014
Non-Final Action Written
Feb 21, 2014
Sn Assigned For Sect 66a Appl From Ib
Feb 24, 2014
New Application Office Supplied Data Entered
Feb 24, 2014
Assigned To Examiner
Feb 25, 2014
Non-Final Action (Ib Refusal) Prepared For Review
Feb 25, 2014
Refusal Processed By Mpu
Feb 25, 2014
Non-Final Action Mailed - Refusal Sent To Ib
Feb 28, 2014
Application Filing Receipt Mailed
Mar 14, 2014
Refusal Processed By Ib
Aug 25, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 25, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 25, 2014
Teas Response To Office Action Received
Aug 25, 2014
Correspondence Received In Law Office
Aug 26, 2014
Teas/Email Correspondence Entered
Aug 29, 2014
Final Refusal Written
Aug 29, 2014
Notification Of Final Refusal Emailed
Aug 29, 2014
Final Refusal E-Mailed
Mar 2, 2015
Teas Request For Reconsideration Received
Mar 2, 2015
Exparte Appeal Received At Ttab
Mar 3, 2015
Jurisdiction Restored To Examining Attorney
Mar 3, 2015
Ex Parte Appeal-Instituted
Mar 9, 2015
Assigned To Lie
Apr 27, 2015
Examiners Amendment E-Mailed
Mar 12, 2015
Teas/Email Correspondence Entered
Mar 12, 2015
Correspondence Received In Law Office
Apr 27, 2015
Notification Of Examiners Amendment E-Mailed
Apr 27, 2015
Examiners Amendment -Written
Apr 27, 2015
Examiner's Amendment Entered
Apr 27, 2015
Approved For Pub - Principal Register
Apr 27, 2015
Law Office Publication Review Completed
May 13, 2015
Notification Of Notice Of Publication E-Mailed
May 13, 2015
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
May 13, 2015
Notification Of Possible Opposition Sent To Ib
Jun 2, 2015
Official Gazette Publication Confirmation E-Mailed
Jun 1, 2015
Notification Processed By Ib
Jun 2, 2015
Published For Opposition
Jul 22, 2015
Notification Of Possible Opposition Created, To Be Sent To Ib
Jul 22, 2015
Notification Of Possible Opposition Sent To Ib
Aug 7, 2015
Notification Of Possible Opposition - Processed By Ib
Aug 18, 2015
Registered-Principal Register
Aug 19, 2015
Exparte Appeal Terminated
Nov 18, 2015
Final Disposition Notice Created, To Be Sent To Ib
Dec 18, 2015
Limitation Of Goods Received From Ib
Feb 2, 2016
Final Disposition Processed
Feb 2, 2016
Final Disposition Notice Sent To Ib
Feb 20, 2016
Final Decision Transaction Processed By Ib
Jul 1, 2016
Correction Under Section 7 - Processed
Jul 6, 2016
Limitation From The Ib Examined And Entered
Mar 1, 2017
Partial Invalidation Of Reg Ext Protection Created
May 2, 2017
Invalidation Reviewed - No Action Required By Office
Sep 21, 2017
Limitation Of Goods Received From Ib
Sep 22, 2017
Correction Transaction Received From Ib
Oct 6, 2017
Limitation Of Goods Received From Ib
Oct 14, 2017
Case Assigned To Post Registration Paralegal
Oct 14, 2017
Correction Under Section 7 - Processed
Oct 16, 2017
Correction From Ib Entered - No Review Required
Aug 18, 2020
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Nov 28, 2017
Limitation From The Ib Examined And Entered
Mar 12, 2018
Case Assigned To Post Registration Paralegal
Mar 12, 2018
Correction Under Section 7 - Processed
Mar 13, 2018
Limitation From The Ib Examined And Entered
Nov 12, 2018
Partial Invalidation Of Reg Ext Protection Created
Nov 29, 2018
Invalidation Reviewed - No Action Required By Office
Aug 16, 2021
Teas Section 71 Received
Jun 6, 2022
Case Assigned To Post Registration Paralegal
Jun 12, 2022
Registered - Partial Sec 71 Accepted
Jul 14, 2023
International Registration Renewed
Jun 12, 2022
Notice Of Acceptance Of Sec. 71 - E-Mailed
Feb 12, 2023
Partial Invalidation Of Reg Ext Protection Created
Apr 4, 2023
Invalidation Processed
Apr 4, 2023
Partial Invalidation Of Reg Ext Protection Sent To Ib
May 16, 2023
Partial Invalidation Processed By The Ib
Aug 18, 2024
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24